迈瑞医疗
(300760)
| 流通市值：2432.33亿 | | | 总市值：2432.40亿 |
| 流通股本：12.12亿 | | | 总股本：12.12亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 25,833,906,543 | 16,743,003,854 | 8,237,179,005 | 36,725,749,548 |
| 营业收入 | 25,833,906,543 | 16,743,003,854 | 8,237,179,005 | 36,725,749,548 |
| 二、营业总成本 | 17,055,866,071 | 10,992,966,764 | 5,312,791,042 | 24,096,446,217 |
| 营业成本 | 9,829,018,551 | 6,418,018,807 | 3,086,814,486 | 13,547,519,384 |
| 税金及附加 | 302,964,242 | 197,869,656 | 101,576,655 | 400,539,455 |
| 销售费用 | 3,735,210,386 | 2,423,934,190 | 1,178,303,701 | 5,282,806,736 |
| 管理费用 | 1,046,880,948 | 682,196,711 | 341,910,867 | 1,599,747,932 |
| 研发费用 | 2,434,870,090 | 1,606,602,668 | 766,538,112 | 3,665,860,585 |
| 财务费用 | -293,078,146 | -335,655,268 | -162,352,779 | -400,027,875 |
| 其中:利息费用 | 16,751,412 | 10,300,387 | 4,987,662 | 19,413,638 |
| 其中:利息收入 | 358,085,286 | 236,093,967 | 114,347,050 | 557,483,566 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 669,858 | 250,473 | - | 126,027,776 |
| 加:投资收益 | 111,310,332 | 100,922,057 | 96,084,286 | 69,390,139 |
| 资产处置收益 | 9,892,876 | 736,574 | -1,080,485 | 4,243,844 |
| 资产减值损失(新) | -203,062,364 | -108,538,077 | -42,890,136 | -237,841,474 |
| 信用减值损失(新) | -156,211,934 | -120,961,914 | -101,167,194 | -299,628,516 |
| 其他收益 | 406,772,773 | 299,959,868 | 172,742,368 | 820,329,290 |
| 四、营业利润 | 8,947,412,013 | 5,922,406,071 | 3,048,076,802 | 13,111,824,390 |
| 加:营业外收入 | 18,911,609 | 12,607,181 | 9,902,432 | 36,762,786 |
| 减:营业外支出 | 64,711,790 | 18,107,171 | 3,757,296 | 128,890,977 |
| 五、利润总额 | 8,901,611,832 | 5,916,906,081 | 3,054,221,938 | 13,019,696,199 |
| 减:所得税费用 | 1,087,718,256 | 684,213,893 | 361,670,908 | 1,279,729,557 |
| 六、净利润 | 7,813,893,576 | 5,232,692,188 | 2,692,551,030 | 11,739,966,642 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 7,813,893,576 | 5,232,692,188 | 2,692,551,030 | 11,739,966,642 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 7,570,044,518 | 5,068,767,098 | 2,628,580,553 | 11,668,487,164 |
| 少数股东损益 | 243,849,058 | 163,925,090 | 63,970,477 | 71,479,478 |
| 扣除非经常损益后的净利润 | 7,462,681,541 | 4,949,323,103 | 2,530,581,109 | 11,442,036,083 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 6.25 | 4.18 | 2.17 | 9.64 |
| (二)稀释每股收益 | 6.25 | 4.18 | 2.17 | 9.63 |
| 八、其他综合收益 | 399,264,979 | 479,585,047 | 127,681,943 | -190,446,947 |
| 归属于母公司股东的其他综合收益 | 368,192,867 | 449,177,546 | 122,145,257 | -157,132,364 |
| 九、综合收益总额 | 8,213,158,555 | 5,712,277,235 | 2,820,232,973 | 11,549,519,695 |
| 归属于母公司股东的综合收益总额 | 7,938,237,385 | 5,517,944,644 | 2,750,725,810 | 11,511,354,800 |
| 归属于少数股东的综合收益总额 | 274,921,170 | 194,332,591 | 69,507,163 | 38,164,895 |
| 公告日期 | 2025-10-30 | 2025-08-28 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |